 |
|
|
| |
Studies of the Potential for Resistance to Nitazoxanide or Tizoxanide in HCV Replicon-Containing Cell Lines
|
| |
| |
Reported by Jules Levin
43rd EASL, April 2008, Milan Italy
Brent E. Korba1*, Menashe Elazar2, Ping Lui2, Jean-Francois Rossignol2,3 and Jeffrey S. Glenn2
1 - Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, DC, USA 2- Division of Gastroenterology & Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA 3 - The Romark Institute for Medical Research, Tampa, FL, USA
|
| |
|
|
|
|
|
